KFU. Card publication. Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

ADRENALINE AUTOINJECTOR IS UNDER-PRESCRIBED IN TYPICAL COLD URTICARIA PATIENTS LIVING IN TROPICAL CLIMATE COUNTRIES

Form of presentation

Articles in international journals and collections

Year of publication

2022

��

��

Authors, employees of KFU

Klyucharova Aliya Rafailovna, author

Bibliographic description in the original language

Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries Mojca Bizjak, Mitja Košnik, Dejan Dinevski 1, Simon Francis Thomsen, Daria Fomina 2 3, Elena Borzova 4 5, Kanokvalai Kulthanan, Raisa Meshkova, FernandoM Aarestrup 6, Dalia Melina Ahsan 7 8, Mona Al-Ahmad 9, Sabine Altrichter, Andrea Bauer 10, Maxi Brockstädt 7 8, Célia Costa 11, Semra Demir 12, Roberta Fachini Criado 13, Luis Felipe Ensina 14, Asli Gelincik 12, Ana Maria Giménez-Arnau 15, Margarida Gonçalo 16, Maia Gotua 17, Jesper Grønlund Holm 18, Naoko Inomata 19, Alicja Kasperska-Zajac 20, Maryam Khoshkhui 21, Aliya Klyucharova 22 23, Emek Kocatürk 24, Rongbiao Lu 25, Michael Makris 26, Natalya Maltseva 2, Maria Pasali 26, Marisa Paulino 11, David Pesqué 15, Jonny Peter 27 28, German Dario Ramón 29, Carla Ritchie 30, Solange Oliveira Rodrigues Valle 31, Michael Rudenko 32, Agnieszka Sikora 20, Nicola Wagner 33, Qatar Med J. 2022 Mar 24;2022(2):19

Annotation

Qatar Med J

Keywords

ColdA; ColdU

The name of the journal

Qatar Med J

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=283695&p_lang=2

Resource files

File name	Size (MB)	Format
F_qmj_2022_fqac_019.pdf	0,19	pdf	show / download

Full metadata record

Field DC	Value	Language
dc.contributor.author	Klyucharova Aliya Rafailovna	ru_RU
dc.date.accessioned	2022-01-01T00:00:00Z	ru_RU
dc.date.available	2022-01-01T00:00:00Z	ru_RU
dc.date.issued	2022	ru_RU
dc.identifier.citation	Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries Mojca Bizjak, Mitja Košnik, Dejan Dinevski 1, Simon Francis Thomsen, Daria Fomina 2 3, Elena Borzova 4 5, Kanokvalai Kulthanan, Raisa Meshkova, FernandoM Aarestrup 6, Dalia Melina Ahsan 7 8, Mona Al-Ahmad 9, Sabine Altrichter, Andrea Bauer 10, Maxi Brockstädt 7 8, Célia Costa 11, Semra Demir 12, Roberta Fachini Criado 13, Luis Felipe Ensina 14, Asli Gelincik 12, Ana Maria Giménez-Arnau 15, Margarida Gonçalo 16, Maia Gotua 17, Jesper Grønlund Holm 18, Naoko Inomata 19, Alicja Kasperska-Zajac 20, Maryam Khoshkhui 21, Aliya Klyucharova 22 23, Emek Kocatürk 24, Rongbiao Lu 25, Michael Makris 26, Natalya Maltseva 2, Maria Pasali 26, Marisa Paulino 11, David Pesqué 15, Jonny Peter 27 28, German Dario Ramón 29, Carla Ritchie 30, Solange Oliveira Rodrigues Valle 31, Michael Rudenko 32, Agnieszka Sikora 20, Nicola Wagner 33, Qatar Med J. 2022 Mar 24;2022(2):19	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=283695&p_lang=2	ru_RU
dc.description.abstract	Qatar Med J	ru_RU
dc.description.abstract	Background: The diagnosis of typical cold urticaria (ColdU) relies on whealing in response to local cold stimulation testing (CST). It can also manifest with cold-induced anaphylaxis (ColdA). Till date, it is largely unclear how often patients with ColdU receive adrenaline treatment and are provided with an adrenaline autoinjector (AAI). Methods: An international, cross-sectional study, COLD-CE (i.e., comprehensive evaluation of ColdU and other cold-induced reactions), was carried out at 32 UCAREs. Detailed histories were taken and CST with an ice cube and/or TempTest? performed. ColdA was defined as an acute cold-induced (i.e., by cold water, air, or surfaces) involvement of the skin and/or visible mucosal tissue and at least one of the symptoms (cardiovascular manifestations, difficulty breathing, or gastrointestinal symptoms). Results: Of the 551 ColdU patients, 75% (n = 412) had a positive CST. Of them, concomitant chronic spontaneous urticaria was diagnosed in 10%. Of 372 patients with stand-alone ColdU, 69% were women and 91% adults. Their median age was 36 (IQR 26 - 48) years. Patients were also categorized into residents of countries with a tropical (n = 33), temperate (n = 264), or cold (n = 75) climate (Table 1: R13C1, R17C1, R21C1). AAI was more often prescribed to residents of temperate than tropical countries (30% vs. 12%, p = .038; Table 1: R31C1), although the frequency of ColdA did not significantly differ between these countries (44% vs. 42%, p = 1.000; R29C2). Residents of tropical countries had a higher frequency of ColdA induced by cold air than residents of temperate (36% vs. 12%, p = .001; R29C4) or cold (36% vs. 12%, p = .007; R25C4) countries. Cardiovascular manifestations induced by cold air were diagnosed in 33% (n = 11) of residents of tropical countries, but only 18% (n = 2) and 36% (n = 4) of them had received adrenaline and AAI, respectively (R13 - 15C7). Furthermore, hypotension and/or loss of consciousness induced by cold air occurred in 18% (n = 6) of patients, but only 17% (n = 1) received adrenaline (R13 - 14C10). ColdA was induced by complete cold water immersion in 9% (n = 3) of patients, and none of them received adrenaline treatment nor AAI (R13 - 15C3). Conclusion: Our findings suggest that ColdA is undertreated and call for changes in ColdU management.	ru_RU
dc.language.iso	ru	ru_RU
dc.subject		ru_RU
dc.title	Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries	ru_RU
dc.type	Articles in international journals and collections	ru_RU